Crossmark

Examining tailoring as an implementation strategy for reducing healthcare-associated infections across European acute care hospitals (REVERSE): study protocol for a hybrid type 2 effectiveness-implementation trial

Crossref DOI link: https://doi.org/10.1186/s13063-025-09132-x

Published Online: 2025-10-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Albers, Bianca https://orcid.org/0000-0001-9555-0547
Caci, Laura

Blum, Kathrin

Boland, Greet

Carrara, Elena

Gentil, Pilar Retamar

Nguyen, Aude

Pollard, Jack

Schechner, Vered

Sonpar, Ashlesha

Yanagida, Takuya

Zingg, Walter

Consortium, Lauren Clack on behalf of the REVER
Funding

Funding for this research was provided by:

European Commission (965265)
License Information

Text and Data Mining valid from 2025-10-16

Version of Record valid from 2025-10-16
More Information

Article History

Received: 20 December 2024

Accepted: 5 September 2025

First Online: 16 October 2025

Declarations

:

: Ethical approval for REVERSE was obtained from the cantonal Ethics Commission of Zurich (AO_2021-00078). Additionally, all participating hospitals obtained ethical approval for their participation in REVERSE from relevant local ethics committees. Written consent to participate in REVERSE will be requested from all study participants invited to respond to surveys and participate in interviews.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below